The Research Unit
More than 300 different and distinct diseases affect the bones,
joints, and supporting structures such as ligaments, tendons and
cartilage. Many of these diseases are congenital (present at birth) and
a great many are also inherited. For only a handful is the cause
presently known.
Shriners Hospitals have always been involved in clinical research.
In 1973, Dr Francis Glorieux was appointed director of research and
founded the research unit at the Canadian Shriners Hospital. Today, the
department counts an average of 65 full-time staff (researchers,
technical personnel, post-doctoral and graduate students and
administrative support staff) who work on more than 15 different
research projects. The research unit is currently recruiting to add to
the researcher roster.
The research unit of the Shriners Hospital - Canada is affiliated
with McGill University in Montreal. The program includes a basic
science component focusing on the study metabolic bone development and
disorders as well as connective tissue function and abnormalities; a
clinical component focusing on the study of osteogenesis
imperfecta (brittle-bone disease) and genetic abnormalities such as
vitamin-D-resistant rickets and other heritable bone diseases.
The
Canadian research facility is among the most important in the Shriners
Hospitals network and the most advanced worldwide in the research and
treatment of OI. Funding for the research labs, which totals nearly $5
million a year, comes either directly from the research program of the
Shriners Hospitals or from granting agencies and industry.
The research unit also maintains a bone histology laboratory, an electron microscopy facility and a computer facility.
Find out information about Genetics Unit of the Shriners Hospital for Children in Montreal, Canada.
Research Affiliations
The research labs at Shriners Hospital - Canada have a strong
affiliation with McGill University in Montreal. All principal
investigators of the Shriners Hospital-Canada hold academic
appointments at McGill University, some in several departments. Several
researchers also hold professorial appointments at Université de
Montréal. Post-doctoral and graduate students in the research
department, as well as the clinical fellows training in paediatric
metabolic bone disease, are registered at McGill University.
We also rely on McGill for compliance matters, such as human subjects (IRB) and administration of government funding.
Principal Investigators and Projects
There are presently nine principal investigators working in the research department:
Francis H. Glorieux, OC, M.D., Ph.D.
-clinical investigation of osteogenesis imperfecta (OI) and other heritable bone diseases.
Reggie Hamdy, M.D.
-research on the effect of BMP-7 on distraction osteogenesis, as well as in outcomes and multicenter studies.
Eunice R. Lee, Ph.D.
-the study of the cartilage/bone interface in growth and disease.
John S. Mort, Ph.D.
-research on connective tissue matrix degradation.
Frank T. Rauch, M.D.
-head of the the Bone Morphology unit with special interest in cortical bone development
-in charge of the clinical laboratories and clinical research
Anneliese Recklies, Ph.D.
- research on endogenous defense mechanisms, to prevent cartilage degradation.
-in charge of the computer and electronic data facility.
Peter Roughley, Ph.D.
-connective tissue and
pathophysiology project as well as in the molecular diagnosis program
(supported in part through the hospital budget)
René St-Arnaud, Ph.D.
-research on vitamin D synthesis and its role in bone as well as gene expression in bone cells.
Pierre Moffatt, Ph.D.
-research to characterize new proteins secreted by the bone-forming cell, the osteoblast.